Stock_Titan Posted - 04/30/24

$SPRY ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Application to EMA’s CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand https://www.stocktitan.net/news/SPRY/ars-pharmaceuticals-submits-response-for-neffy-r-epinephrine-nasal-ebqvz78qhjyc.html

Squalewally Posted - 04/29/24

@dennisjackson @Tjcmd Try and make contact with your pea brain. AQST isn’t a one trick pony as $SPRY is. AQST’s drug is also superior.

prototyper Posted - 04/29/24

$SPRY my puts lost its premiums little . I see slow bleed and bleeding

Divergence88 Posted - 04/29/24

@InfiniteTrades @YouVSYou $SPRY a more superior product to what? Maybe the other epinephrine sprays that are being developed, but definitely not Anaphylm. The only thing that SPRY has going for it right now that WS has recognized is that it's more likely to be approved before $AQST's Anaphylm, but that won't matter once Anaphylm is approved in a little over a year. Anaphylm will be the superior product on the market and will command the majority of the Anaphylaxis market share.

YouVSYou Posted - 04/26/24

Compared to $SPRY which is trading at $8.35 (zero revenue), $AQST which earns revenues of $50m annually is criminally undervalued. Libervant which was approved today will add $200m to that number. Anaphylm in 2025 - another $1 billion

BioEmerging Posted - 04/24/24

$SPRY stock grants are a bit piggish.

CNayak88 Posted - 04/23/24

$SPRY is this a good company?

ABCDEFGHIJKLMNOPQRSTUVX Posted - 04/18/24

$SPRY SPRY lost the SMA50 for now. Could be a good buy opportunity at the SMA200 at low 6s... can buy and keep adding if it goes to 5.

briank012345 Posted - 04/18/24

@ABCDEFGHIJKLMNOPQRSTUVX I was thinking the exact same thing this morning. It would not be a good look for $SPRY to sue $AQST, in turn relegating children to having only a rectal solution. A potential lawsuit could really be a PR boon for $AQST (lemonade out of lemons) and also bring ODE under further heightened scrutiny.

prototyper Posted - 04/18/24

$SPRY insiders starting to sellout? They gonna start unloading shares imo

insiderbuyingselling Posted - 04/17/24

$SPRY new insider selling: 100000 shares. http://insiderbuyingselling.com/?t=SPRY

ABCDEFGHIJKLMNOPQRSTUVX Posted - 04/17/24

$SPRY Schwab just reported that they dumped 4M shares.... FMR Capital previously dumped 4M shares last month.

RCaptain Posted - 04/12/24

@BioEmerging $SPRY has big insider and tute support. Scaredy cat retail here.

prototyper Posted - 04/12/24

$SPRY anyone holding put option through fda approval timeline?

BioEmerging Posted - 04/12/24

$SPRY holding up well today. Questi not so much. $AQST

martynlucas Posted - 04/11/24

$SPRY

martynlucas Posted - 04/11/24

$SPRY SPRY Stock - ARS Pharmaceuticals Fundamental Technical Analysis Review LIVE Now on YouTube https://www.youtube.com/watch?v=UEwh2I0S5n8 #SPRY #ARS #MartynLucasInvestor

ABCDEFGHIJKLMNOPQRSTUVX Posted - 04/11/24

$AQST don't take any advice from me. What I am doing is holding AQST till $10. And I am buying $spry hopefully once it bleeds to $5 and will hold it until pdufa and sell at $10 also.

insiderbuyingselling Posted - 04/10/24

$SPRY new insider selling: 100000 shares. http://insiderbuyingselling.com/?t=SPRY

BioEmerging Posted - 04/09/24

$AQST questi got no gas after offering and $spry doing well. Still, questi can deliver 4-5x from here . Be long in both.

optiresearch Posted - 04/07/24

$SPRY PRICE TARGET $18. Their adrenaline nasal spray product will get approved as soon as Q1 2025. Biotech wallstreet analysts predict this stock goes higher because they understand the medicine is safe and effective in treating allergic reactions. Their easy to use adrenaline nasal spray replaces the Epipen injectable. Mylan's Epipen patent expires in 2025, thus weakening competition.

Tradewolf101 Posted - 04/05/24

$SPRY $SKYT bullish. Love this daily chart $SKYT

ABCDEFGHIJKLMNOPQRSTUVX Posted - 04/05/24

$SPRY 100% manipulation. Without any catalysts for 6 months, stock price should languish to 6s and then move up September. If it keeps going up, it is manipulation.

vjtweet Posted - 04/04/24

$SPRY long

ONLYPHARMS Posted - 04/04/24

$SPRY with a one trick pony like spry…. i guess its going to be a long long 6 months with nothong else to look forward to… have a good summer!

fda_tracker Posted - 04/04/24

$SPRY New PDUFA Date 2024-10-02 ARS Pharmaceuticals, Inc. Link:https://www.globenewswire.com/news-release/2024/04/03/2857016/0/en/ARS-Pharmaceuticals-Submits-Response-to-FDA-Complete-Response-Letter-for-neffy-Epinephrine-Nasal-Spray.html Calendar:http://www.fdatracker.com/fda-calendar/

StockLearner2023 Posted - 04/04/24

$SPRY So, now the formal SPRY's response to CRL has just filed, SPRY 's market cap is almost $1 billion, so almost 90% of approval chance is priced in already. Any negative outcome would be devastating to investors. One thing predictable about FDA is their unpredictability. SPRY's last CRL is a big proof of that. Good luck to all.

StockLearner2023 Posted - 04/03/24

$AQST $SPRY SPRY has almost the same shelf registration in place:

Stock_Titan Posted - 04/03/24

$SPRY ARS Pharmaceuticals Submits Response to FDA Complete Response Letter for neffy® (Epinephrine Nasal Spray) https://www.stocktitan.net/news/SPRY/ars-pharmaceuticals-submits-response-to-fda-complete-response-letter-hf3tvvtp3d7q.html

optiresearch Posted - 04/02/24

$SPRY adrenaline in a nasal spray. It has been in inhalers for decades. Proven to work great against asthma attacks. This adrenaline nasal spray will save lives, preventing anaphylaxis in kids and adults having allergic reactions to peanuts, shellfish, insect bites, mold, etc. PRICE TARGET $18